AppHarvest (NASDAQ:APPH – Get Rating) and Yield10 Bioscience (NASDAQ:YTEN – Get Rating) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.
Valuation and Earnings
This table compares AppHarvest and Yield10 Bioscience’s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AppHarvest | $14.59 million | 3.75 | -$176.65 million | ($1.63) | -0.22 |
| Yield10 Bioscience | $450,000.00 | 31.44 | -$13.57 million | ($2.84) | -0.83 |
Yield10 Bioscience has lower revenue, but higher earnings than AppHarvest. Yield10 Bioscience is trading at a lower price-to-earnings ratio than AppHarvest, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Profitability
This table compares AppHarvest and Yield10 Bioscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AppHarvest | -800.58% | -45.62% | -24.02% |
| Yield10 Bioscience | -3,882.82% | -243.41% | -143.90% |
Institutional and Insider Ownership
31.7% of AppHarvest shares are owned by institutional investors. Comparatively, 7.7% of Yield10 Bioscience shares are owned by institutional investors. 13.4% of AppHarvest shares are owned by insiders. Comparatively, 9.4% of Yield10 Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent ratings and target prices for AppHarvest and Yield10 Bioscience, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AppHarvest | 0 | 2 | 1 | 0 | 2.33 |
| Yield10 Bioscience | 0 | 0 | 0 | 0 | N/A |
AppHarvest currently has a consensus price target of $1.50, indicating a potential upside of 324.69%. Given AppHarvest’s higher probable upside, analysts clearly believe AppHarvest is more favorable than Yield10 Bioscience.
Summary
AppHarvest beats Yield10 Bioscience on 11 of the 13 factors compared between the two stocks.
About AppHarvest
AppHarvest, Inc., an applied agricultural technology company, develops and operates indoor farms to grow non-GMO produce free of chemical pesticide residues. Its products include tomatoes; and other fruits and vegetables, such as berries, peppers, cucumbers, and salad greens. The company was incorporated in 2018 and is based in Morehead, Kentucky.
About Yield10 Bioscience
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Receive News & Ratings for AppHarvest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AppHarvest and related companies with MarketBeat.com's FREE daily email newsletter.
